Cheryl Scacheri: Lead Editor

Cheryl Scacheri is the Lead Editor for our Genetics and Society Topic Room.

Biographical Sketch

Cheryl Scacheri

Cheryl Scacheri is Senior Vice President and Director of Clinical Operations at Clear Path Group, where she is responsible for the development of CPG's genetic risk assessment tool and genetic counseling service. A board-certified genetic counselor, she was previously Director of Genomics Education and Policy at Cleveland Clinic and served on the Executive Leadership Team of Cleveland Clinic's Genomic Medicine Institute. While at Cleveland Clinic, Cheryl played a key role in the expansion of genetics services throughout the institution. In addition, she spearheaded an unprecedented institution-wide genetics education initiative with the goal of improving patient care for familial conditions and employee wellness.

Cheryl has been a genetic counselor in clinical and research laboratories at the University of Pittsburgh Medical Center, Children's National Medical Center and GeneDx, Inc. In academia, she coordinated research studies, published peer-reviewed articles, authored chapters in medical textbooks, organized scientific conferences and provided genetic counseling to patients. In her four years at GeneDx, Inc., she became Director of Genetic Counseling Services, served on the Executive Staff, and played a key role in the company's quintupling of revenue and personnel. In addition, throughout her career, she has been dedicated to genetics education, teaching basic science students and genetic counseling students at Johns Hopkins University, George Washington University and University of Pittsburgh, among others. She currently serves on the Editorial Board of Scitable, an online genetics program by Nature Publishing Group.

Cheryl is committed to public policy issues in genetics and is a member of the Genetic Alliance in Washington, DC. She served on the Board of Directors of the National Society of Genetic Counselors (NSGC), and continues to be an active member of the Public Policy Committee of the NSGC. As co-chair of the Licensure Committee of Ohio, her current efforts in policy are focused on obtaining licensure for genetic counselors in the state.

In 2008, Cheryl had the honor of being the first recipient of the NSGC's Strategic Leader award. She holds an MS degree in genetic counseling from the University of Pittsburgh and a bachelor's degree from Drew University in Madison, NJ. She is a diplomate of the American Board of Genetic Counseling.


Flag Inappropriate

This content is currently under construction.
All Articles Within Genetics and Society (38)

Genetic Diagnosis and Disease Risks (5)

Genetic Testing and Human Impact (8)

Ethical Considerations (9)

  • Medical Ethics: Genetic Testing and Spinal Muscular Atrophy
    The mutation that causes Spinal Muscular Atrophy (SMA) can be detected in a prenatal screen. But a parent's decision to test for this terrible disease is not as easy as you would think.
  • Genetic Inequality: Human Genetic Engineering
    As genetics allows us to turn the tide on human disease, it's also granting the power to engineer desirable traits into humans. What limits should we create as this technology develops?
  • Human Testing, the Eugenics Movement, and IRBs
    The eugenics movement of the early 1900s ultimately went horribly wrong despite its noble aims. What can we learn from this movement’s outcomes in order to avoid the repetition of these mistakes?
  • Bioethics in Genetics
    Can bioethics ever represent too much of a good thing? Where exactly is the line between too little and too much protection for patients in genetic counseling, research, and testing?
  • Diagnostic Testing and the Ethics of Patenting DNA
    Intellectual property rights offset the financial risks of funding research but limit information access. Can a balance between private interests and public desire for treatments be achieved?
  • Embryo Screening and the Ethics of Human Genetic Engineering
    What if you could screen embryos for diseases before they became babies? What if you had the power to choose the traits your baby would have? Would you use it?
  • Protecting Your Genetic Identity: GINA and HIPAA
    Genomics could enable the misuse and abuse of our most personal information. On the other hand, could genetic privacy acts like GINA and HIPAA close the shutters on progress in health research?
  • Questionable Prognostic Value of Genetic Testing
    Many experts predict that genetic testing for disease susceptibility is well on its way to becoming a routine part of clinical care. Yet many of the genetic tests currently being developed are, in the words of the World Health Organization (WHO), of “questionable prognostic value.” How can this be?
  • Ethics of Genetic Testing: Medical Insurance and Genetic Discrimination
    For disorders that are preventable or treatable, most people agree that genetic testing makes sense. But for diseases with no preventative measures, would you want to know if you were affected?

Genetically-Tailored Treatment (6)

Social Uses of Genetic Discovery (7)

Genetics and the Law (5)

  • Diagnostic Testing and the Ethics of Patenting DNA
    Intellectual property rights offset the financial risks of funding research but limit information access. Can a balance between private interests and public desire for treatments be achieved?
  • Protecting Your Genetic Identity: GINA and HIPAA
    Genomics could enable the misuse and abuse of our most personal information. On the other hand, could genetic privacy acts like GINA and HIPAA close the shutters on progress in health research?
  • Forensics, DNA Fingerprinting, and CODIS
    How ethical is it to keep a database of convicted felons' DNA profiles? Can we rely on DNA fingerprints for conviction? Many ethical issues surround the use of DNA in forensic technology.
  • Legislative Landmarks of Forensics: California v. Greenwood and Shed DNA
    Everywhere we go, we leave our DNA behind. Forensics profits from this “abandoned” DNA to solve crimes. As technology improves, could we wind up with a database of everyone’s DNA – including yours?
  • Sports, Gene Doping, and WADA
    Gene doping could stretch the physical limits of human strength and endurance. What are the consequences of gene therapy in sports competition, and more, importantly, is it safe?
 
Ask an Expert
Post Question



Nature Education Home Learn More About Faculty Page Students Page Feedback



Genetics

Event Reminder